Contributions of the receptor for advanced glycation end products axis activation in gastric cancer

World J Gastroenterol. 2023 Feb 14;29(6):997-1010. doi: 10.3748/wjg.v29.i6.997.

Abstract

Compelling shreds of evidence derived from both clinical and experimental research have demonstrated the crucial contribution of receptor for advanced glycation end products (RAGE) axis activation in the development of neoplasms, including gastric cancer (GC). This new actor in tumor biology plays an important role in the onset of a crucial and long-lasting inflammatory milieu, not only by supporting phenotypic changes favoring growth and dissemination of tumor cells, but also by functioning as a pattern-recognition receptor in the inflammatory response to Helicobacter pylori infection. In the present review, we aim to highlight how the overexpression and activation of the RAGE axis contributes to the proliferation and survival of GC cells as and their acquisition of more invasive phenotypes that promote dissemination and metastasis. Finally, the contribution of some single nucleotide polymorphisms in the RAGE gene as susceptibility or poor prognosis factors is also discussed.

Keywords: Advanced glycation end-products; Alarmins; Chronic inflammation; Gastric cancer; Helicobacter pylori; Receptor of advanced glycation end-products.

Publication types

  • Review

MeSH terms

  • Glycation End Products, Advanced
  • Helicobacter Infections* / complications
  • Helicobacter pylori*
  • Humans
  • Receptor for Advanced Glycation End Products / genetics
  • Receptors, Pattern Recognition
  • Stomach Neoplasms* / genetics

Substances

  • Receptor for Advanced Glycation End Products
  • Receptors, Pattern Recognition
  • Glycation End Products, Advanced